Engineered neutrophil membrane nanosystem for targeted siRNA therapy in myocardial ischemia–reperfusion injury
Year: 2025
Type: article
Language: en
Topic: Cardiac Ischemia and Reperfusion
Authors and affiliations:
raw_author_name: Yaohui Jiang
raw_affiliation_strings: Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Henan Key Laboratory of Coronary Heart Disease Control & Prevention, Central China Fuwai Hospital of Zhengzhou University, No. 1 Fuwai Road, Zhengzhou, Henan, China
Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
raw_author_name: Zhe Wang
raw_affiliation_strings: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China
Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China
raw_author_name: Penglei Chen
raw_affiliation_strings: Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Department of Thoracic Surgery, Wuxi Peoples Hospital, Wuxi Medical Center, The Affiliated Wuxi Peoples Hospital of Nanjing Medical University, Nanjing Medical University, Wuxi, 214023, China
raw_author_name: He Lu
raw_affiliation_strings: Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, Jiangsu, China
Department of Radiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China
raw_author_name: Xiaoxu Tian
raw_affiliation_strings: Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Henan Key Laboratory of Coronary Heart Disease Control & Prevention, Central China Fuwai Hospital of Zhengzhou University, No. 1 Fuwai Road, Zhengzhou, Henan, China
raw_author_name: Pin Jiang
raw_affiliation_strings: Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, MOE Innovation Center for Basic Research in Tumor Immunotherapy, Hefei, 230022, Anhui, China
Department of General Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China
raw_author_name: Rui Luo
raw_affiliation_strings: Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
raw_author_name: Yujing Zhou
raw_affiliation_strings: Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
raw_author_name: Zhikang Lv
raw_affiliation_strings: Department of Cardiac Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
raw_author_name: Wenjun Mao
raw_affiliation_strings: Department of Thoracic Surgery, Wuxi Peoples Hospital, Wuxi Medical Center, The Affiliated Wuxi Peoples Hospital of Nanjing Medical University, Nanjing Medical University, Wuxi, 214023, China
raw_author_name: Shuai Ren
raw_affiliation_strings: Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, Jiangsu, China. shuairen@njucm.edu.cn
raw_author_name: Xiaocheng Wang
raw_affiliation_strings: Anhui Province Key Laboratory of Tumor Immune Microenvironment and Immunotherapy, MOE Innovation Center for Basic Research in Tumor Immunotherapy, Hefei, 230022, Anhui, China. xcwang@fy.ahmu.edu.cn
Department of Rheumatology and Immunology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China. xcwang@fy.ahmu.edu.cn
raw_author_name: Haiqiang Sang
raw_affiliation_strings: Department of Cardiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. fccsanghq@zzu.edu.cn
raw_author_name: Wei Yang
raw_affiliation_strings: Department of Cardiology, Fuwai Central China Cardiovascular Hospital, Henan Key Laboratory of Coronary Heart Disease Control & Prevention, Central China Fuwai Hospital of Zhengzhou University, No. 1 Fuwai Road, Zhengzhou, Henan, China. ywyy2008@163.com